H.R.2483 — SUPPORT for Patients and Communities Reauthorization Act of 2025
House Roll Call
H.R.2483
| Bill | H.R.2483 — SUPPORT for Patients and Communities Reauthorization Act of 2025 |
|---|---|
| Vote question | On Agreeing to the Amendment |
| Vote type | Recorded Vote |
| Result | Failed |
| Totals | Yea 213 / Nay 213 / Present 0 / Not Voting 12 |
| Party | Yea | Nay | Present | Not Voting |
|---|---|---|---|---|
| R | 2 | 213 | 0 | 8 |
| D | 211 | 0 | 0 | 4 |
| I | 0 | 0 | 0 | 0 |
Research Brief
On Agreeing to the Amendment
Bill Analysis
The SUPPORT for Patients and Communities Reauthorization Act of 2025 (HR 2483) aims to enhance and extend various initiatives established under previous legislation to combat the opioid epidemic and improve substance use disorder treatment across the United States. This law reauthorizes key provisions of the SUPPORT Act, originally enacted in 2018, and introduces new measures to strengthen the healthcare response to addiction.
Key provisions include the reauthorization of funding for state and local programs that provide treatment and recovery services for individuals with substance use disorders. The bill allocates resources to the Substance Abuse and Mental Health Services Administration (SAMHSA) to support the development of comprehensive treatment programs, including medication-assisted treatment (MAT) and behavioral therapies. Additionally, it expands access to telehealth services, allowing patients to receive care remotely, which is particularly beneficial in rural and underserved areas.
The legislation also mandates the establishment of new grant programs aimed at improving the coordination of care among healthcare providers, enhancing data sharing, and increasing the availability of naloxone, an opioid overdose reversal drug. Furthermore, it includes provisions to bolster workforce training for healthcare professionals in addiction treatment and prevention.
Beneficiaries of the bill include individuals struggling with substance use disorders, their families, and communities disproportionately affected by the opioid crisis. The law also impacts healthcare providers, state and local governments, and public health agencies tasked with implementing these programs.
The bill was signed into law on August 1, 2025, and it sets forth a timeline for the allocation of funds and the implementation of new initiatives, with many programs expected to commence within the fiscal year following enactment. Overall, HR 2483 represents a significant federal commitment to addressing the ongoing challenges posed by substance use disorders in the U.S.
Yea (213)
J
Jason Crow
L
Lloyd Doggett
J
John Garamendi
J
John Mannion
L
Lucy McBath
E
Eric Swalwell
R
Rashida Tlaib
N
Nydia Velázquez
D
Debbie Wasserman Schultz
Nay (213)
K
Ken Calvert
S
Scott Franklin
M
Mark Green
L
Lisa McClain
J
John Rutherford
D
David Schweikert
P
Pete Sessions
